Status:
RECRUITING
Clopidogrel Versus Aspirin MOnotherapy After 1- to 3-month of Dual-antiplatelet thErapy Following Zotarolimus-eluting Onyx Stents Implantation; C-MODE Trial
Lead Sponsor:
Yonsei University
Conditions:
Ischemic Heart Disease
Eligibility:
All Genders
19-84 years
Phase:
NA
Brief Summary
Previous randomized clinical trials have deomonstrated the efficacy and safety of short-term dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), however, the single antipl...
Detailed Description
The investigators hypothesized that short-term (1-3 months) DAPT followed by clopidogrel monotherapy will be superior to short-term DAPT followed by aspirin monotherapy after PCI in patients with isch...
Eligibility Criteria
Inclusion
- Patients ≥19 years
- Patients who received new generation zotarolimus-eluting Onyx stents implantation for treating ischemic heart disease
- Provision of informed consent
Exclusion
- Age ≥ 85 years
- Acute myocardial infarction
- 2\. Left main bifurcation requiring 2-stent technique 3. Pregnant women or women with potential childbearing 4. Life expectancy \< 1 year 5. Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator 6. Inability to understand or read the informed consent
Key Trial Info
Start Date :
July 26 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 10 2028
Estimated Enrollment :
3744 Patients enrolled
Trial Details
Trial ID
NCT05320926
Start Date
July 26 2022
End Date
July 10 2028
Last Update
October 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei University Health System, Severance Hospital
Seoul, South Korea